These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 33069744)
1. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases. Ni J; Miao T; Su M; Khan NU; Ju X; Chen H; Liu F; Han L J Control Release; 2021 Jan; 329():934-947. PubMed ID: 33069744 [TBL] [Abstract][Full Text] [Related]
2. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy. Mu R; Sun H; Zeng Y; Tong Y; Tang P; Zhao M; Lv Z; Yu J; Chen Y; Lan Q; Zhen X; Han L J Control Release; 2024 May; 369():458-474. PubMed ID: 38575077 [TBL] [Abstract][Full Text] [Related]
3. Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages. Zhang T; Lip H; He C; Cai P; Wang Z; Henderson JT; Rauth AM; Wu XY Adv Healthc Mater; 2019 Sep; 8(18):e1900543. PubMed ID: 31348614 [TBL] [Abstract][Full Text] [Related]
4. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases. Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546 [TBL] [Abstract][Full Text] [Related]
5. Biology of breast cancer brain metastases and novel therapies targeting the blood brain barrier: an updated review. Zhao H; Wang L; Ji X; Zhang L; Li C Med Oncol; 2023 May; 40(6):181. PubMed ID: 37202575 [TBL] [Abstract][Full Text] [Related]
6. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases. Ju X; Miao T; Chen H; Ni J; Han L Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958 [TBL] [Abstract][Full Text] [Related]
7. A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer. Li J; Cai P; Shalviri A; Henderson JT; He C; Foltz WD; Prasad P; Brodersen PM; Chen Y; DaCosta R; Rauth AM; Wu XY ACS Nano; 2014 Oct; 8(10):9925-40. PubMed ID: 25307677 [TBL] [Abstract][Full Text] [Related]
8. Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases. Carney CP; Pandey N; Kapur A; Woodworth GF; Winkles JA; Kim AJ Drug Deliv Transl Res; 2021 Dec; 11(6):2344-2370. PubMed ID: 34716900 [TBL] [Abstract][Full Text] [Related]
9. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677 [TBL] [Abstract][Full Text] [Related]
10. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment. Khan NU; Ni J; Ju X; Miao T; Chen H; Han L Acta Pharm Sin B; 2021 May; 11(5):1341-1354. PubMed ID: 34094838 [TBL] [Abstract][Full Text] [Related]
11. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Cui Y; Xu Q; Chow PK; Wang D; Wang CH Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444 [TBL] [Abstract][Full Text] [Related]
14. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003 [TBL] [Abstract][Full Text] [Related]
16. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases. Wyatt EA; Davis ME Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770 [TBL] [Abstract][Full Text] [Related]
18. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies. Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445 [TBL] [Abstract][Full Text] [Related]
19. Are capecitabine and the active metabolite 5-Fu CNS penetrable to treat breast cancer brain metastasis? Zhang J; Zhang L; Yan Y; Li S; Xie L; Zhong W; Lv J; Zhang X; Bai Y; Cheng Z Drug Metab Dispos; 2015 Mar; 43(3):411-7. PubMed ID: 25547867 [TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis. Zhang C; Pan Y; Cai R; Guo S; Zhang X; Xue Y; Wang J; Huang J; Wang J; Gu Y; Zhang Z Neuropharmacology; 2020 May; 167():107980. PubMed ID: 32014448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]